Literature DB >> 19500277

Lack of inherited mutations of PTPRD in familial melanoma and melanoma-astrocytoma syndrome.

David A Solomon, Jung-Sik Kim, Xiaohong R Yang, Margaret A Tucker, Alisa M Goldstein, Yardena Samuels, Todd Waldman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19500277      PMCID： PMC2758084          DOI： 10.1111/j.1755-148X.2009.00587.x

Source DB:  PubMed          Journal:  Pigment Cell Melanoma Res        ISSN： 1755-1471            Impact factor:   4.693


× No keyword cloud information.
  24 in total

1.  Identification of chromosome arm 9p as the most frequent target of homozygous deletions in lung cancer.

Authors:  Masamitsu Sato; Kenji Takahashi; Kazuhiro Nagayama; Yasuhito Arai; Nobue Ito; Mitsumasa Okada; John D Minna; Jun Yokota; Takashi Kohno
Journal:  Genes Chromosomes Cancer       Date:  2005-12       Impact factor: 5.006

2.  Distinct sets of genetic alterations in melanoma.

Authors:  John A Curtin; Jane Fridlyand; Toshiro Kageshita; Hetal N Patel; Klaus J Busam; Heinz Kutzner; Kwang-Hyun Cho; Setsuya Aiba; Eva-Bettina Bröcker; Philip E LeBoit; Dan Pinkel; Boris C Bastian
Journal:  N Engl J Med       Date:  2005-11-17       Impact factor: 91.245

3.  Homozygous deletions and chromosome amplifications in human lung carcinomas revealed by single nucleotide polymorphism array analysis.

Authors:  Xiaojun Zhao; Barbara A Weir; Thomas LaFramboise; Ming Lin; Rameen Beroukhim; Levi Garraway; Javad Beheshti; Jeffrey C Lee; Katsuhiko Naoki; William G Richards; David Sugarbaker; Fei Chen; Mark A Rubin; Pasi A Jänne; Luc Girard; John Minna; David Christiani; Cheng Li; William R Sellers; Matthew Meyerson
Journal:  Cancer Res       Date:  2005-07-01       Impact factor: 12.701

4.  A survey of homozygous deletions in human cancer genomes.

Authors:  Charles Cox; Graham Bignell; Chris Greenman; Arne Stabenau; William Warren; Philip Stephens; Helen Davies; Stephen Watt; Jon Teague; Sara Edkins; Ewan Birney; Douglas F Easton; Richard Wooster; P Andrew Futreal; Michael R Stratton
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-10       Impact factor: 11.205

5.  Evidence for three tumor suppressor loci on chromosome 9p involved in melanoma development.

Authors:  P M Pollock; J Welch; N K Hayward
Journal:  Cancer Res       Date:  2001-02-01       Impact factor: 12.701

6.  The selective reduction in PTPdelta expression in hepatomas.

Authors:  N Urushibara; H Karasaki; K Nakamura; Y Mizuno; K Ogawa; K Kikuchi
Journal:  Int J Oncol       Date:  1998-03       Impact factor: 5.650

7.  Mutational inactivation of PTPRD in glioblastoma multiforme and malignant melanoma.

Authors:  David A Solomon; Jung-Sik Kim; Julia C Cronin; Zita Sibenaller; Timothy Ryken; Steven A Rosenberg; Habtom Ressom; Walter Jean; Darell Bigner; Hai Yan; Yardena Samuels; Todd Waldman
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

8.  Functional evidence of novel tumor suppressor genes for cutaneous malignant melanoma.

Authors:  C N Parris; J D Harris; D K Griffin; A P Cuthbert; A J Silver; R F Newbold
Journal:  Cancer Res       Date:  1999-02-01       Impact factor: 12.701

9.  Chromosome 9p deletions in cutaneous malignant melanoma tumors: the minimal deleted region involves markers outside the p16 (CDKN2) gene.

Authors:  S Puig; A Ruiz; C Lázaro; T Castel; M Lynch; J Palou; A Vilalta; J Weissenbach; J M Mascaro; X Estivill
Journal:  Am J Hum Genet       Date:  1995-08       Impact factor: 11.025

10.  Familial cutaneous malignant melanoma and tumors of the nervous system. A hereditary cancer syndrome.

Authors:  E Azizi; J Friedman; F Pavlotsky; J Iscovich; A Bornstein; R Shafir; H Trau; H Brenner; D Nass
Journal:  Cancer       Date:  1995-11-01       Impact factor: 6.860
View more
  3 in total

1.  Reduced expression of PTPRD correlates with poor prognosis in gastric adenocarcinoma.

Authors:  Dandan Wang; Leilei Wang; Jun Zhou; Jihong Pan; Wei Qian; Jiafang Fu; Genglin Zhang; Youming Zhu; Chunshan Liu; Chunliang Wang; Zongkun Jin; Ziqing He; Jianmei Wu; Bin Shi
Journal:  PLoS One       Date:  2014-11-20       Impact factor: 3.240

2.  Deletion of Ptprd and Cdkn2a cooperate to accelerate tumorigenesis.

Authors:  Berenice Ortiz; Julie R White; Wei H Wu; Timothy A Chan
Journal:  Oncotarget       Date:  2014-08-30

3.  A large de novo 9p21.3 deletion in a girl affected by astrocytoma and multiple melanoma.

Authors:  Simona Frigerio; Vittoria Disciglio; Siranoush Manoukian; Bernard Peissel; Gabriella Della Torre; Andrea Maurichi; Paola Collini; Barbara Pasini; Giacomo Gotti; Andrea Ferrari; Licia Rivoltini; Maura Massimino; Monica Rodolfo
Journal:  BMC Med Genet       Date:  2014-05-17       Impact factor: 2.103
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.